COVID-19 Benchmarking Survey

Client Alert | less than 1 min read | 03.16.20

We thank our clients for your input on our effort to help contractors benchmark what companies are doing as part of COVID-19 contingency planning. Please use the survey link below to access the brief benchmarking questionnaire. Assuming we have a sufficient number of responses, we will aggregate and share responses (on an anonymous basis).

Access the survey here.

Please contact David Robbins with any questions.

Contacts

Peter Eyre
Partner
He/Him/His
- Washington, D.C.
  - D | +1.202.624.2807
cGV5cmVAY3Jvd2VsbC5jb20=
Daniel R. Forman
Partner
He/Him/His
- Washington, D.C.
  - D | +1.202.624.2504
ZGZvcm1hbkBjcm93ZWxsLmNvbQ==

Insights

Client Alert | 3 min read | 03.02.26

Changes to UK Clinical Trials Regulations Take Effect April 28, 2026. New Versions of UK Model Clinical Trial Agreement Forms Pending.

Clinical trial sponsors and all other stakeholders involved in conducting commercial clinical trials of investigational medicinal products (IMP) in the UK....

Client Alert | 4 min read | 03.02.26
Ex parte Reexamination: Strategic Considerations for Patent Challengers in Light of Recent PTAB Policy Changes
Client Alert | 3 min read | 02.27.26
EEOC v. Coca-Cola Beverages Northeast, Inc.: Another Step Focused on the EEOC’s Goal of Eradicating Unlawful DEI-Related Practices
Client Alert | 6 min read | 02.27.26
Major Questions, Major Drama

View All Insights